Bonjour,
voici un article dans le revue scientifique internationale "Harm Reduction Journal" qui fait suite à l'enquete que Psychoactif avait lancé sur l'injection intraveineuse de
skenan (morphine) (
https://www.psychoactif.org/forum/2022/ … 242_1.html )
Abstract
"People who inject oral
morphine favor experimentation with injectable opioid
substitution"
https://harmreductionjournal.biomedcent … 23-00866-yThe French Addictovigilance network has observed the existence of the intravenous use of oral
morphine capsules among people suffering from opioid use disorders. According to persons who inject
morphine, these capsules are easy to dissolve and then inject, giving them the image of an "injectable" opioid
substitution treatment (OST). In France, validated OSTs are only available orally, so dissolving
morphine capsules represents the only alternative for patients who are not sufficiently relieved by oral forms.
This practice presents risks related to the potential persistence of particles of the oral galenic in the injectable solution, despite its filtration, but also risks—notably of overdose—related to the pharmacological effects of opioids and to variations of the quantities of
morphine extracted during the dissolution of the capsules. We conducted an online survey among the people concerned to collect data on their needs and expectations regarding a possible injectable
substitution.
Dernière modification par pierre (22 septembre 2023 à 17:32)